Kenta Takaura

Musashino, 1808610, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.

Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.

Journal: Nutrients

Published: April 01, 2026

Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.

Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.

Journal: Diagnostics (Basel, Switzerland)

Published: March 30, 2026

Lactulose and rifaximin combination therapy as first-line treatment for preventing recurrent overt hepatic encephalopathy: a retrospective observational study.

Lactulose and rifaximin combination therapy as first-line treatment for preventing recurrent overt hepatic encephalopathy: a retrospective observational study.

Journal: European journal of gastroenterology & hepatology

Published: November 17, 2025

Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds.

Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds.

Journal: Journal of clinical medicine

Published: October 07, 2025

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Journal: PloS one

Published: June 08, 2025

Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.

Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis.

Journal: Diagnostics (Basel, Switzerland)

Published: May 23, 2024

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 27, 2023

Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.

Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: October 17, 2023

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Journal of gastroenterology and hepatology

Published: October 10, 2023

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: October 01, 2023

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Journal: Clinical case reports

Published: May 02, 2023

Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.

Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.

Journal: Quantitative imaging in medicine and surgery

Published: April 19, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026